New Nordic EMBL Partnership for Molecular Medicine will advance the understanding of molecular mechanisms underpinning disease
The partnership between EMBL, the Institute for Molecular Medicine Finland, the Centre for Molecular Medicine Norway and the Laboratory for Molecular Infection Medicine Sweden is dedicated to molecular medicine, a growing field in the life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments.
“Each partner has a long history of research in specific areas relevant to molecular medicine and brings in a unique set of expertise, skills and facilities,” says Iain Mattaj, Chair of the partnership's steering committee and Director General at EMBL. “Combining complementary strengths in the new Nordic EMBL Partnership equips us to tackle some of the most challenging problems of biomedicine.”
EMBL's recognised research strengths in the areas of molecular, cellular and developmental biology, bioinformatics and structural biology will be complemented by Norway's expertise in molecular mechanisms of disease, Sweden's focus on microbial pathogenicity and molecular infection medicine and Finland's strength in genetic epidemiology.
The agreement will facilitate access to scientific infrastructure, including databases, facilities and instrumentation, as well as to services and training activities provided by the partners. The partnership will result in the adoption of the EMBL model for international recruitment, staff turnover and scientific reviews by the Nordic nodes. The coordination between the Nordic nodes and EMBL will be overseen by a steering committee constituted by two representatives from each node. Scientific progress will be reviewed regularly by a committee of external experts. In addition to their partnership with EMBL the individual Nordic research centres will engage in collaborations with other national partners, including research and public health institutes, hospitals and research councils, to establish an extensive Nordic network for molecular medicine.
Anna-Lynn Wegener
Press Officer
EMBL
Meyerhofstrasse 1
D-69117 Heidelberg
tel. +49-6221-3878452
fax +49-6221-387525
wegener@embl.de
Media Contact
All latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…
